- Home
- HCC vs SRRK Comparison
HCC vs SRRK Comparison
Compare HCC & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCC
- SRRK
- Stock Information
- Founded
- HCC 2015
- SRRK 2012
- Country
- HCC United States
- SRRK United States
- Employees
- HCC N/A
- SRRK N/A
- Industry
- HCC Coal Mining
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HCC Energy
- SRRK Health Care
- Exchange
- HCC Nasdaq
- SRRK Nasdaq
- Market Cap
- HCC 2.5B
- SRRK 2.8B
- IPO Year
- HCC 2017
- SRRK 2018
- Fundamental
- Price
- HCC $45.67
- SRRK $29.06
- Analyst Decision
- HCC Strong Buy
- SRRK Strong Buy
- Analyst Count
- HCC 5
- SRRK 6
- Target Price
- HCC $70.25
- SRRK $42.17
- AVG Volume (30 Days)
- HCC 871.0K
- SRRK 1.1M
- Earning Date
- HCC 04-30-2025
- SRRK 05-14-2025
- Dividend Yield
- HCC 0.70%
- SRRK N/A
- EPS Growth
- HCC N/A
- SRRK N/A
- EPS
- HCC 2.01
- SRRK N/A
- Revenue
- HCC $1,319,451,000.00
- SRRK N/A
- Revenue This Year
- HCC N/A
- SRRK N/A
- Revenue Next Year
- HCC $31.98
- SRRK $452.64
- P/E Ratio
- HCC $22.57
- SRRK N/A
- Revenue Growth
- HCC N/A
- SRRK N/A
- 52 Week Low
- HCC $38.00
- SRRK $6.76
- 52 Week High
- HCC $75.53
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- HCC 47.06
- SRRK 42.92
- Support Level
- HCC $44.81
- SRRK $28.29
- Resistance Level
- HCC $48.68
- SRRK $31.60
- Average True Range (ATR)
- HCC 1.75
- SRRK 1.53
- MACD
- HCC -0.13
- SRRK -0.17
- Stochastic Oscillator
- HCC 33.11
- SRRK 14.49
About HCC Warrior Met Coal Inc.
Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.